France
# |
Name |
Dividends Paid |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 0.00
|
Dec. 31, 2023 | USD 1.64 | 4.90% |
|
France |
|
2 |
USD 0.00
|
Dec. 31, 2023 | USD 5.91 | -2.66% |
|
France |
|
3 |
USD 0.00
|
Dec. 31, 2023 | USD 5.64 | -2.27% |
|
France |
|
4 |
USD 0.00
|
Dec. 31, 2023 | USD 2.58 | -11.21% |
|
France |
|
5 |
USD 0.00
|
Dec. 31, 2023 | USD 1.45 | 1.71% |
|
France |
|
6 |
USD 0.00
|
Dec. 31, 2023 | USD 2.03 | 3.98% |
|
France |
|
7 |
USD 0.00
|
Dec. 31, 2023 | USD 3.55 | 2.04% |
|
France |
|
8 |
USD 0.00
|
Dec. 31, 2023 | USD 3.87 | -3.39% |
|
France |
|
9 |
USD 0.00
|
Dec. 31, 2023 | USD 1.39 | 1.77% |
|
France |
|
10 |
USD 0.00
|
Dec. 31, 2023 | USD 3.91 | 3.55% |
|
France |
|
11 |
USD 0.00
|
Dec. 31, 2023 | USD 2.01 | -0.78% |
|
France |
|
12 |
USD 0.00
|
Dec. 31, 2023 | USD 2.43 | 0.68% |
|
France |
|
13 |
USD 0.00
|
Dec. 31, 2023 | USD 7.66 | 0.25% |
|
France |
|
14 |
USD 0.00
|
March 31, 2024 | USD 16.83 | 1.50% |
|
France |
|
15 |
USD 0.00
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
16 |
USD 0.00
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
17 |
USD 0.00
|
Dec. 31, 2023 | USD 6.63 | -0.22% |
|
France |
|
18 |
USD 0.00
|
Dec. 31, 2023 | USD 2.06 | -0.75% |
|
France |
|
19 |
USD 0.00
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
The Clinical Trials company in France with the highest Dividends Paid is AB Science S.A. (Paris Stock Exchange: AB.PA) at USD 0.00.
The Clinical Trials company in France with the lowest Dividends Paid is DBV Technologies S.A. (NasdaqCM: DBVT) at USD 0.00.
The top 10 Clinical Trials companies in France by Dividends Paid are AB Science S.A., ABIVAX SA, Adocia SA, Aelis Farma SA, Affluent Medical SA, Crossject SA, Median Technologies SA, Predilife S.A., Valbiotis SA and Genfit S.A..
The bottom 10 Clinical Trials companies in France by Dividends Paid are DBV Technologies S.A., Advicenne S.A., OSE Immunotherapeutics SA, Novacyt S.A., Nanobiotix S.A., MedinCell S.A., MaaT Pharma SA, Inventiva S.A., Innate Pharma S.A. and Genfit S.A..